Ask AI
ProCE Banner Activity

DTR-Pseudomonas aeruginosa: Applying Best Practices in Complex Clinical Scenarios

Podcast Episodes

Hear experts apply the latest data and guidance recommendations on optimizing antimicrobial therapy for complex clinical infections involving Pseudomonas aeruginosa with difficult-to-treat resistance.

Released: November 16, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Merck & Co., Inc.

Merck & Co., Inc.

Disclosure

Program Director

Trevor Van Schooneveld, MD, FSHEA, FACP, FIDSA

Professor, Division of Infectious Diseases
Medical Director, Antimicrobial Stewardship Program
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Trevor Van Schooneveld, MD, FSHEA, FACPconsultant/advisor/speaker: bioMérieux, Thermo Fisher; researcher: AN2 Therapeutics, Insmed.

Primary Author

Emily Heil, PharmD, MS, BCIDP, AAHIVP

Professor
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, Maryland

Emily Heil, PharmD, MS, BCIDP, AAHIVP: consultant/advisor/speaker: Wolters Klewer.

Laila Woc-Colburn, MD

Associate Professor
Divsion of Infectious Disesases
Emory University School of Medicine
Emory Healthcare
Atlanta, Georgia

Laila Woc-Colburn, MD, has no relevant financial relationships to disclose.